Australia markets open in 7 hours 50 minutes

Humacyte, Inc. (HUMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.9600+0.0300 (+0.61%)
As of 12:10PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 587.09M
Enterprise value 490.15M
Trailing P/E 1.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)22.45
Enterprise value/revenue N/A
Enterprise value/EBITDA 4.34

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 362.71%
S&P500 52-week change 324.96%
52-week high 39.9700
52-week low 31.9600
50-day moving average 35.6637
200-day moving average 33.6579

Share statistics

Avg vol (3-month) 32.37M
Avg vol (10-day) 32.85M
Shares outstanding 5119.08M
Implied shares outstanding 6119.08M
Float 883.19M
% held by insiders 130.67%
% held by institutions 119.84%
Shares short (31 May 2024) 44.91M
Short ratio (31 May 2024) 41.71
Short % of float (31 May 2024) 45.44%
Short % of shares outstanding (31 May 2024) 44.13%
Shares short (prior month 30 Apr 2024) 44.49M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-36.66%
Return on equity (ttm)-195.68%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -93.57M
Net income avi to common (ttm)-105.7M
Diluted EPS (ttm)-1.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)115.5M
Total cash per share (mrq)0.97
Total debt (mrq)18.57M
Total debt/equity (mrq)71.00%
Current ratio (mrq)8.37
Book value per share (mrq)0.22

Cash flow statement

Operating cash flow (ttm)-82.01M
Levered free cash flow (ttm)-52.05M